The company, which is focused on research, development and production of pharmaceutical, nutraceutical and cosmetic products, has executed an option agreement for a land purchase of a 5,328m²
The kit has been designed for use in imaging and intraoperative detection of sentinel lymph nodes draining a primary tumor in adult patients with breast cancer, melanoma or
Started in late July 2014, the Phase IIa trial is being conducted under an investigational new drug (IND) application filed by the company’s licensor, the Blanchette Rockefeller Neuroscience
As part of the deal, the two parties will jointly work on projects, based on an overarching research plan, in the HBV and liver cancer fields with funding
Recently, the company has also started a multi-centre Phase Ib trial of BGB324, a selective inhibitor of Axl, in AML patients. The two-part trial is primarily designed to
The Omega-3 fish oil will be sold under the name ‘TapouT’ with all revenues flowing directly into Axxess Pharma. Omega-3 fatty acids are some of the most important
Currently, the company is preparing a new drug application (NDA) for MM-398 in the US to treat these patients with metastatic pancreatic cancer. The FDA fast track status
The NDA was based on an international, randomized, multicenter, double-blind, relapse prevention Phase III trial of paliperidone palmitate three-month injection. More than 500 patients were included in the
NHPN-1010 is being developed to treat noise-induced hearing loss (NIHL) and Cisplatin-induced hearing loss (CIHL). The Phase I trial will determine the safety, tolerability and pharmacokinetic (PK) profile
As part of the deal, Sunshine will manufacture Adva-27a using Lonza’s expertise and experience in small molecule development and manufacturing of active pharmaceutical ingredients. The Swiss firm’s manufacturing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.